{"slug":"ss-31-insomnia","verification":{"valid":true,"entries":2,"head":"04bf902f21ef95636ad4a553fe336d72cddf3bcf03986a75b48b164fc75506ff"},"energy":{"passes":2,"tokens_in":17666,"tokens_out":2635,"tokens_total":20301,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"04bf902f21ef95636ad4a553fe336d72cddf3bcf03986a75b48b164fc75506ff"},"provenance":[{"ts":"2026-06-29T23:51:53.151Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Insomnia\nSlug: ss-31-insomnia\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **SS-31 (Elamipretide)** → mitochondrial\",\"section_headings\":[\"What's breaking down\",\"Why SS-31 (Elamipretide) might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merg","response":"{\n  \"slug\": \"ss-31-insomnia\",\n  \"title\": \"SS-31 (Elamipretide) for Insomnia: Evidence Review\",\n  \"body\": \"## What's breaking down\\n\\nInsomnia often links to cycles where poor sleep increases oxidative stress and inflammation in brain cells. Mitochondria in neurons produce less efficient energy. This can worsen cognitive fog and make sustained sleep harder. Degeneration outpaces repair when mitochondrial cardiolipin gets damaged, leading to more reactive oxygen species and weaker synaptic function. SS-31 targets that mitochondrial layer for potential repair rather than symptom suppression.\\n\\n## Why SS-31 (Elamipretide) might help you\\n\\nIf mitochondrial dysfunction in brain cells contributes to your insomnia pattern, SS-31 is discussed because it binds cardiolipin in the inner mitochondrial membrane. Step 1: It stabilizes electron transport chain efficiency. Step 2: This reduces excess ROS production during sleep-deprived states. Step 3: Lower ROS and inflammation may support better synaptic plasticity and energy availability overnight. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain or forces drowsiness.\\n\\n## How these fit together\\n\\nSingle-compound focus. SS-31 (Elamipretide) maps to the mitochondrial degeneration layer. No siblings in scope.\\n\\n## What the evidence actually shows\\n\\nTwo mouse studies address sleep deprivation models directly. Zhang 2024 gave chronic sleep deprivation to mice then treated with elamipretide; it restored SIRT1 and PGC-1α levels, lowered inflammatory cytokines (IL-1β, IL-6, TNF-α), and improved learning/memory performance (preclinical). Wu 2020 used short-term sleep deprivation in aging mice; SS-31 prevented learning deficits, restored hippocampal mitochondrial ATP, and lowered ROS plus cytokines (preclinical). No human trials test SS-31 for insomnia or primary sleep outcomes. Human data come from mitochondrial myopathy and he","tokens_in":17666,"tokens_out":2635,"cost":0,"prev":"genesis","hash":"4af3bec7c4aacd7d0ca5f5610eb493c573da48008dd0e975f212953e3408aa6a"},{"ts":"2026-07-17T02:42:05.547Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-insomnia","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"4af3bec7c4aacd7d0ca5f5610eb493c573da48008dd0e975f212953e3408aa6a","hash":"04bf902f21ef95636ad4a553fe336d72cddf3bcf03986a75b48b164fc75506ff"}]}